Riverain Technologies’ FDA-cleared ClearRead™ Chest suite is available through the Rapid Enterprise™ Platform , alongside a full-body portfolio of deep clinical AI within a consistent, connected workflow. Designed for chest CTs and X-rays, ClearRead Chest helps radiologists detect, characterize and visualize pulmonary nodules, pneumothoraces and coronary artery calcifications. The integration brings Riverain’s chest imaging AI together with RapidAI’s full-body deep clinical AI portfolio of more than 50 clinical solutions, all in a connected, consistent workflow.